Byong Duk Ye

97PUBLICATIONS
300CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersKorean languageInnate immunityHorticultural crop improvement (incl. selection and breeding)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Sep 22, 2026
Cumulative Local and Metachronous Recurrence Rates in Patients with Ulcerative Colitis-Associated Neoplasia after Endoscopic Submucosal Dissection.

|Sep 13, 2026
Optimizing Endoscopic Assessment of Postoperative Crohn's Disease: A Scoping Review.

|Jun 29, 2026
Five-Year Outcomes and Disease Trajectories in Moderate-to-Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort.

|Jun 22, 2026
Semen Discoloration Following Upadacitinib Therapy in Patients with Inflammatory Bowel Disease.

|May 01, 2026
Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.

|Mar 25, 2026
Pharmacokinetics and efficacy of subcutaneous infliximab 120 mg every 2 weeks: a post hoc comparison with intravenous dosing in a phase 1 study in patients with inflammatory bowel disease.

Stefan Schreiber, Byong Duk Ye, Hyunseong Yu

Pageof 17

Frequent Collaborators

43 joint publications

Suk-Kyun Yang

40 joint publications

Sang Hyoung Park

20 joint publications

Jeong-Sik Byeon

19 joint publications

Sung Wook Hwang